Table 4.
Univariate Linear Regression Model |
Multiple Linear Regress Model (Method: Full) |
Multiple Linear Regress Model (Method: Stepwise) |
% of Increments or Decrements (Stepwise) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
β | SE | p- Value | β | SE | p -Value | β | SE | p -Value | % * | Amount (CNY) # | |
Intercept | N. A | N. A | N. A | 8.49 | 0.36 | <0.01 | 8.99 | 0.16 | <0.01 | — | 8022 (ref) |
Female (ref = Male) | 0.06 | 0.11 | 0.56 | 0.12 | 0.09 | 0.21 | |||||
Age groups (ref: ≥40 years) | |||||||||||
<18 years | 0.10 | 0.17 | 0.53 | −0.03 | 0.15 | 0.82 | |||||
18–39 years | −0.04 | 0.06 | 0.53 | −0.07 | 0.06 | 0.23 | |||||
Disease duration (ref = ≤3 years) | |||||||||||
3–8 years | −0.36 | 0.07 | <0.01 | −0.08 | 0.07 | 0.23 | |||||
>8 years | −0.31 | 0.07 | <0.01 | −0.10 | 0.07 | 0.15 | |||||
Region (ref: West) | |||||||||||
Central | −0.12 | 0.08 | 0.15 | −0.09 | 0.07 | 0.21 | |||||
Eastern | −0.11 | 0.07 | 0.13 | −0.13 | 0.07 | 0.04 | |||||
Health insurance (ref: None) | −0.03 | 0.08 | 0.67 | −0.15 | 0.07 | 0.03 | −0.13 | 0.07 | 0.04 | −12.2 | −978 |
Hospitalization during last year (ref: None) | 1.32 | 0.06 | <0.01 | 1.19 | 0.06 | <0.01 | 1.22 | 0.06 | <0.01 | 238.7 | 19,150 |
Newly treated patients (ref: Treated patients) |
0.36 | 0.11 | <0.01 | −0.02 | 0.10 | 0.84 | |||||
ANA positive (ref: Negative) | 0.30 | 0.13 | 0.02 | 0.20 | 0.11 | 0.08 | |||||
dsDNA positive (ref: Negative) | 0.04 | 0.07 | 0.54 | 0.04 | 0.06 | 0.53 | |||||
Abnormal liver function (ref: Normal) | 0.13 | 0.07 | 0.06 | 0.05 | 0.06 | 0.43 | |||||
Low complement (ref: No) | 0.11 | 0.06 | 0.08 | −0.03 | 0.06 | 0.63 | |||||
Moderate to severe (ref: Mild) | 0.60 | 0.09 | <0.01 | 0.27 | 0.09 | <0.01 | 0.26 | 0.08 | <0.01 | 29.7 | 2382 |
Active disease State (ref: Remission or LLDAS) |
0.46 | 0.06 | <0.01 | 0.06 | 0.08 | 0.47 | |||||
System involvement | |||||||||||
Skin system (ref: Normal) | −0.02 | 0.06 | 0.71 | −0.01 | 0.06 | 0.83 | |||||
Musculoskeletal system (ref: Normal) |
−0.01 | 0.06 | 0.87 | −0.03 | 0.05 | 0.60 | |||||
Peripheral vascular system (ref: Normal) |
0.22 | 0.06 | <0.01 | 0.12 | 0.05 | 0.02 | 0.13 | 0.05 | <0.01 | 13.9 | 1114 |
Serositis (ref: Normal) | 0.33 | 0.06 | <0.01 | 0.01 | 0.10 | 0.90 | |||||
Renal system (ref: Normal) | 0.30 | 0.06 | <0.01 | 0.20 | 0.10 | 0.04 | 0.20 | 0.05 | <0.01 | 22.1 | 1776 |
Neuropsychiatric system (ref: Normal) |
0.10 | 0.11 | 0.38 | 0.01 | 0.10 | 0.94 | |||||
Gastrointestinal system (ref: Normal) |
0.26 | 0.19 | 0.17 | 0.13 | 0.17 | 0.45 | |||||
Ocular system (ref: Normal) | 0.22 | 0.25 | 0.38 | 0.10 | 0.22 | 0.65 | |||||
Cardiovascular system (ref: Normal) |
0.43 | 0.11 | <0.01 | 0.42 | 0.10 | <0.01 | 0.39 | 0.09 | <0.01 | 47.7 | 3826 |
Pulmonary system (ref: Normal) | 0.65 | 0.29 | 0.02 | 0.26 | 0.25 | 0.30 | |||||
2 or more damaged organs (ref: 0 or 1) |
0.25 | 0.07 | <0.01 | −0.01 | 0.08 | 0.89 | |||||
Biologics (ref: Unused) | 0.59 | 0.10 | <0.01 | 0.34 | 0.09 | <0.01 | 0.34 | 0.09 | <0.01 | 40.5 | 3248 |
Glucocorticoids (ref: Unused) | |||||||||||
≤7.5mg/day | −0.09 | 0.08 | 0.24 | −0.01 | 0.07 | 0.92 | −0.02 | 0.07 | 0.73 | −2.0 | −159 |
>7.5mg/d and ≤15mg/day | 0.34 | 0.08 | <0.01 | 0.19 | 0.09 | 0.04 | 0.23 | 0.07 | <0.01 | 25.9 | 2074 |
>15mg/day | 0.60 | 0.08 | <0.01 | 0.24 | 0.10 | 0.01 | 0.30 | 0.08 | <0.01 | 35.0 | 2807 |
* Calculated as: (exp(coefficient) − 1) × 100; # Calculated as: (Exp(coefficient) − 1) × exp (Intercept); Full model: R2 = 0.261; Stepwise model: R2 = 0.254.